Pascal Deschatelets
Chief Scientific Officer · 4 filings · Latest: May 14, 2026
Apellis Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
APLS | Pascal Deschatelets | Chief Scientific Officer | Jan 22, 2026 | Sale | $21.77 | 5,928 | $129.0K | 1,151,382 | |
APLS | Deschatelets Pascal | — | Jan 22, 2026 | Proposed Sale | $21.77 | 5,928 | $129.0K | — | |
APLS | Pascal Deschatelets | Chief Scientific Officer | Jan 20, 2026 | Sale | $19.79 | 909 | $18.0K | 1,157,310 | |
APLS | Deschatelets Pascal | — | Jan 20, 2026 | Proposed Sale | $19.79 | 909 | $18.0K | — | |
APLS | Deschatelets Pascal | — | Jan 13, 2026 | Proposed Sale | $22.19 | 2,277 | $50.5K | — | |
APLS | Deschatelets Pascal | — | Jan 29, 2025 | Proposed Sale | $29.52 | 826 | $24.4K | — | |
APLS | Deschatelets Pascal | — | Jan 22, 2025 | Proposed Sale | $30.43 | 3,948 | $120.1K | — | |
APLS | Deschatelets Pascal | — | Jan 17, 2025 | Proposed Sale | $29.96 | 750 | $22.5K | — | |
APLS | Deschatelets Pascal | — | Jan 13, 2025 | Proposed Sale | $28.70 | 2,331 | $66.9K | — |